{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:29:26Z","timestamp":1793734166860,"version":"4.6.1"},"reference-count":65,"publisher":"American Association for Cancer Research (AACR)","issue":"2","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":110,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008594","name":"European Hematology Association","doi-asserted-by":"publisher","award":["RG-202409-06772"],"award-info":[{"award-number":["RG-202409-06772"]}],"id":[{"id":"10.13039\/100008594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["NG2 and NG4"],"award-info":[{"award-number":["NG2 and NG4"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006704","name":"Ostravsk\u00e1 Univerzita v Ostrav\u011b","doi-asserted-by":"publisher","award":["SGS20\/LF\/2025"],"award-info":[{"award-number":["SGS20\/LF\/2025"]}],"id":[{"id":"10.13039\/501100006704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018857","name":"International Myeloma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018896","name":"Sylvester Comprehensive Cancer Center, University of Miami Health Systems","doi-asserted-by":"publisher","award":["P30 CA 240139"],"award-info":[{"award-number":["P30 CA 240139"]}],"id":[{"id":"10.13039\/100018896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013352","name":"Tow Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Extramedullary multiple myeloma (EMM) is a high-risk feature of multiple myeloma associated with increased resistance to treatments, including modern immunotherapies, and shorter survival. The composition and functional state of immune cells within the EMM tumor microenvironment (TME) remain poorly understood. Using single-cell RNA sequencing, flow cytometry, and spatial transcriptomics, we revealed significant differences in the EMM TME compared with multiple myeloma bone marrow (BM). T and NK cells were verified as the most abundant immune subsets in the EMM TME. Compared with the BM counterparts, we found these tumors to have a significantly reduced effector\u2013to\u2013tumor cell ratio, a significantly lower number of CD4+ T cells, and an increased proportion of regulatory CD16\u2212 NK cells. We observed a high proportion of exhausted, tumor-reactive CD8+ T cells in roughly half of EMM tumors. Furthermore, we identified elevated expression of immune checkpoints, such as PD-1 on CD8+ T cells and KLRC1 (NKG2A) on CD16\u2212 NK cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study characterizes the TME in EMM lesions and paired BM from patients with multiple myeloma, revealing a high proportion of less cytotoxic CD16\u2212 NK cells in EMM tumors and suggesting that direct cell\u2013cell interactions may underlie the CD8+ T-cell exhaustion observed in a subset of these tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-25-0170","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:02:13Z","timestamp":1763132533000},"page":"250-265","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Composition and Functional State of T and NK Cells in the Extramedullary Myeloma Tumor Microenvironment"],"prefix":"10.1158","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2540-6966","authenticated-orcid":false,"given":"Anjana","family":"Anilkumar Sithara","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 3 Department of Biology and Ecology, Faculty of Science, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9937-5667","authenticated-orcid":false,"given":"Veronika","family":"Kapustova","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4585-0773","authenticated-orcid":false,"given":"David","family":"Zihala","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 3 Department of Biology and Ecology, Faculty of Science, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0619-9861","authenticated-orcid":false,"given":"Ondrej","family":"Venglar","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1686-0587","authenticated-orcid":false,"given":"Daniel","family":"Bilek","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 3 Department of Biology and Ecology, Faculty of Science, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-1669","authenticated-orcid":false,"given":"Moutaz","family":"Helal","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03pvr2g57","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital W\u00fcrzburg 4 Mildred Scheel Early Career Center, , W\u00fcrzburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-405X","authenticated-orcid":false,"given":"Mara","family":"John","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03pvr2g57","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital W\u00fcrzburg 4 Mildred Scheel Early Career Center, , W\u00fcrzburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3066-8290","authenticated-orcid":false,"given":"Eva","family":"Radova","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1523-2981","authenticated-orcid":false,"given":"Lucie","family":"Broskevicova","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6171-8516","authenticated-orcid":false,"given":"Jan","family":"Vrana","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0551-4887","authenticated-orcid":false,"given":"Gabriela","family":"Havlova","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 5 Department of Nuclear Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8589-1577","authenticated-orcid":false,"given":"Ludmila","family":"Muronova","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5885-4218","authenticated-orcid":false,"given":"Tereza","family":"Popkova","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6773-7873","authenticated-orcid":false,"given":"Jana","family":"Mihalyova","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0543-7987","authenticated-orcid":false,"given":"Hana","family":"Plonkova","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7699-3879","authenticated-orcid":false,"given":"Serafim","family":"Nenarokov","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."},{"name":"6Institute of Parasitology, Biology Centre, Czech Academy of Sciences, \u010cesk\u00e9 Bud\u011bjovice, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3808-924X","authenticated-orcid":false,"given":"Kamlesh","family":"Bisht","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Sanofi 7 Research and Development, , Cambridge, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1104-1540","authenticated-orcid":false,"given":"Hongfang","family":"Wang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Sanofi 7 Research and Development, , Cambridge, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4126-8289","authenticated-orcid":false,"given":"Helgi","family":"Van de Velde","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Sanofi 7 Research and Development, , Cambridge, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6378-4696","authenticated-orcid":false,"given":"Sandra","family":"Charvatova","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0518-9581","authenticated-orcid":false,"given":"Ivo","family":"Demel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1954-9021","authenticated-orcid":false,"given":"Michal","family":"Kascak","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2067-1253","authenticated-orcid":false,"given":"Milan","family":"Navratil","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7444-5422","authenticated-orcid":false,"given":"Martin","family":"Havel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 5 Department of Nuclear Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2862-4048","authenticated-orcid":false,"given":"Juli","family":"Bago","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2388-2723","authenticated-orcid":false,"given":"Michal","family":"Simicek","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9411-4210","authenticated-orcid":false,"given":"Angela","family":"Riedel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03pvr2g57","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital W\u00fcrzburg 4 Mildred Scheel Early Career Center, , W\u00fcrzburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-9649","authenticated-orcid":false,"given":"Leo","family":"Rasche","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03pvr2g57","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital W\u00fcrzburg 4 Mildred Scheel Early Career Center, , W\u00fcrzburg, Germany."},{"id":[{"id":"https:\/\/ror.org\/03pvr2g57","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital W\u00fcrzburg 8 Department of Internal Medicine II, , W\u00fcrzburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8704-0106","authenticated-orcid":false,"given":"Tereza","family":"Sevcikova","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 3 Department of Biology and Ecology, Faculty of Science, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6485-4839","authenticated-orcid":false,"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0552r4b12","id-type":"ROR","asserted-by":"publisher"}],"name":"Sylvester Comprehensive Cancer Center 9 Sylvester Myeloma Institute, , University of Miami, Miami, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6955-6267","authenticated-orcid":false,"given":"Roman","family":"Hajek","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5467-9253","authenticated-orcid":false,"given":"Tomas","family":"Jelinek","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6yph09","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Ostrava 1 Department of Hematooncology, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/00pyqav47","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Ostrava 2 Department of Hematooncology, Faculty of Medicine, , Ostrava, Czech Republic."},{"id":[{"id":"https:\/\/ror.org\/0552r4b12","id-type":"ROR","asserted-by":"publisher"}],"name":"Sylvester Comprehensive Cancer Center 9 Sylvester Myeloma Institute, , University of Miami, Miami, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"2026030403075081100_bib1","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ajh.27023","article-title":"Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma","volume":"98","author":"Zanwar","year":"2023","journal-title":"Am J Hematol"},{"issue":"Suppl 16","key":"2026030403075081100_bib2","doi-asserted-by":"crossref","first-page":"8002","DOI":"10.1200\/JCO.2023.41.16_suppl.8002","article-title":"First results from the RedirecTT-1 study with teclistamab (tec) + talquetamab (tal) simultaneously targeting BCMA and GPRC5D in patients (pts) with relapsed\/refractory multiple myeloma (RRMM)","volume":"41","author":"Cohen","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026030403075081100_bib3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/bjh.17338","article-title":"Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations","volume":"194","author":"Rosi\u00f1ol","year":"2021","journal-title":"Br J Haematol"},{"key":"2026030403075081100_bib4","first-page":"890","article-title":"Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT","volume":"103","author":"Gagelmann","year":"2018","journal-title":"Haematologica"},{"key":"2026030403075081100_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41375-021-01343-w","article-title":"Limited efficacy of daratumumab in multiple myeloma with extramedullary disease","volume":"36","author":"Jelinek","year":"2022","journal-title":"Leukemia"},{"key":"2026030403075081100_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa2406536","article-title":"Talquetamab plus teclistamab in relapsed or refractory multiple myeloma","volume":"392","author":"Cohen","year":"2025","journal-title":"N Engl J Med"},{"key":"2026030403075081100_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa2203478","article-title":"Teclistamab in relapsed or refractory multiple myeloma","volume":"387","author":"Moreau","year":"2022","journal-title":"N Engl J Med"},{"key":"2026030403075081100_bib8","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1038\/s41591-023-02528-9","article-title":"Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results","volume":"29","author":"Lesokhin","year":"2023","journal-title":"Nat Med"},{"key":"2026030403075081100_bib9","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1056\/NEJMoa2204591","article-title":"Talquetamab, a T-cell-redirecting GPRC5D bispecific antibody for multiple myeloma","volume":"387","author":"Chari","year":"2022","journal-title":"N Engl J Med"},{"key":"2026030403075081100_bib10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00277-021-04447-6","article-title":"Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns","volume":"100","author":"Danhof","year":"2021","journal-title":"Ann Hematol"},{"key":"2026030403075081100_bib11","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1002\/cncr.34987","article-title":"Single-agent belantamab mafodotin in patients with relapsed\/refractory multiple myeloma: final analysis of the DREAMM-2 trial","volume":"129","author":"Nooka","year":"2023","journal-title":"Cancer"},{"key":"2026030403075081100_bib12","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/ajh.27469","article-title":"Clinical outcomes and microenvironment profiling in relapsed\/refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapy","volume":"99","author":"Qi","year":"2024","journal-title":"Am J Hematol"},{"key":"2026030403075081100_bib13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMoa2213614","article-title":"Ide-cel or standard regimens in relapsed and refractory multiple myeloma","volume":"388","author":"Rodriguez-Otero","year":"2023","journal-title":"N Engl J Med"},{"key":"2026030403075081100_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41408-024-01068-w","article-title":"Impact of extraosseous extramedullary disease on outcomes of patients with relapsed-refractory multiple myeloma receiving standard-of-care chimeric antigen receptor T-cell therapy","volume":"14","author":"Dima","year":"2024","journal-title":"Blood Cancer J"},{"key":"2026030403075081100_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: a systematic literature review","volume":"12","author":"Blad\u00e9","year":"2022","journal-title":"Blood Cancer J"},{"key":"2026030403075081100_bib16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00277-012-1414-5","article-title":"Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases","volume":"91","author":"Rasche","year":"2012","journal-title":"Ann Hematol"},{"key":"2026030403075081100_bib17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/1078-0432.CCR-19-0694","article-title":"Alterations in the transcriptional programs of myeloma cells and the microenvironment during extramedullary progression affect proliferation and immune evasion","volume":"26","author":"Ryu","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2026030403075081100_bib18","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41375-024-02206-w","article-title":"Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors","volume":"38","author":"Jelinek","year":"2024","journal-title":"Leukemia"},{"key":"2026030403075081100_bib19","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.2024024590","article-title":"Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma","volume":"144","author":"John","year":"2024","journal-title":"Blood"},{"key":"2026030403075081100_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41408-024-01208-2","article-title":"Whole genome sequencing and the genetics of extramedullary disease in multiple myeloma","volume":"15","author":"Bingham","year":"2025","journal-title":"Blood Cancer J"},{"key":"2026030403075081100_bib21","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1038\/bcj.2016.35","article-title":"Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses","volume":"6","author":"de Haart","year":"2016","journal-title":"Blood Cancer J"},{"key":"2026030403075081100_bib22","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2024-203350","article-title":"The mutational landscape of extramedullary multiple myeloma reveals novel biologic insights and potential therapeutic targets for exploration","volume":"144","author":"Zanwar","year":"2024","journal-title":"Blood"},{"key":"2026030403075081100_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ejh.12688","article-title":"Cytogenetics in multiple myeloma patients progressing into extramedullary disease","volume":"97","author":"Besse","year":"2016","journal-title":"Eur J Haematol"},{"key":"2026030403075081100_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41408-024-01131-6","article-title":"Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease","volume":"14","author":"Stork","year":"2024","journal-title":"Blood Cancer J"},{"key":"2026030403075081100_bib25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/PAS.0000000000001459","article-title":"Genetic basis of extramedullary plasmablastic transformation of multiple myeloma","volume":"44","author":"Liu","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"2026030403075081100_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.blre.2015.08.004","article-title":"Monoclonal antibodies \u2014 a new era in the treatment of multiple myeloma","volume":"30","author":"Jelinek","year":"2016","journal-title":"Blood Rev"},{"key":"2026030403075081100_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev-med-050522-033815","article-title":"New biological therapies for multiple myeloma","volume":"75","author":"Garfall","year":"2024","journal-title":"Annu Rev Med"},{"key":"2026030403075081100_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41408-024-01139-y","article-title":"Bispecific antibodies in the treatment of multiple myeloma","volume":"14","author":"Devasia","year":"2024","journal-title":"Blood Cancer J"},{"key":"2026030403075081100_bib29","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-18-1597","article-title":"The mechanism of action of the anti-CD38 monoclonal antibody isatuximab in multiple myeloma","volume":"25","author":"Moreno","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026030403075081100_bib30","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.2023023529","article-title":"NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myeloma","volume":"144","author":"Blanquart","year":"2024","journal-title":"Blood"},{"key":"2026030403075081100_bib31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"key":"2026030403075081100_bib32","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.2024026455","article-title":"The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy","volume":"145","author":"Korst","year":"2025","journal-title":"Blood"},{"key":"2026030403075081100_bib33","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ajh.27590","article-title":"Level of clonal plasma cells in hematopoietic cell autografts reflects the pre-transplant bone marrow minimal residual disease in multiple myeloma patients","volume":"100","author":"Venglar","year":"2025","journal-title":"Am J Hematol"},{"key":"2026030403075081100_bib34","doi-asserted-by":"crossref","first-page":"eabl5197","DOI":"10.1126\/science.abl5197","article-title":"Cross-tissue immune cell analysis reveals tissue-specific features in humans","volume":"376","author":"Dom\u00ednguez Conde","year":"2022","journal-title":"Science"},{"key":"2026030403075081100_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2023.02.008","article-title":"The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients","volume":"41","author":"Friedrich","year":"2023","journal-title":"Cancer Cell"},{"key":"2026030403075081100_bib36","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/cyto.a.20643","article-title":"Phenotype and function of human T lymphocyte subsets: consensus and issues","volume":"73","author":"Appay","year":"2008","journal-title":"Cytometry A"},{"key":"2026030403075081100_bib37","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.abl5447","article-title":"Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers","volume":"375","author":"Lowery","year":"2022","journal-title":"Science"},{"key":"2026030403075081100_bib38","doi-asserted-by":"crossref","first-page":"816499","DOI":"10.3389\/fimmu.2021.816499","article-title":"Natural killer cells in the malignant niche of multiple myeloma","volume":"12","author":"Venglar","year":"2021","journal-title":"Front Immunol"},{"key":"2026030403075081100_bib39","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andr\u00e9","year":"2018","journal-title":"Cell"},{"key":"2026030403075081100_bib40","doi-asserted-by":"crossref","first-page":"20332","DOI":"10.1002\/cam4.6619","article-title":"Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma","volume":"12","author":"Bisht","year":"2023","journal-title":"Cancer Med"},{"key":"2026030403075081100_bib41","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/bloodadvances.2020003805","article-title":"Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma","volume":"5","author":"Verkleij","year":"2021","journal-title":"Blood Adv"},{"key":"2026030403075081100_bib42","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1158\/1078-0432.CCR-23-3333","article-title":"T-cell characteristics impact response and resistance to T-cell\u2013redirecting bispecific antibodies in multiple myeloma","volume":"30","author":"Verkleij","year":"2024","journal-title":"Clin Cancer Res"},{"key":"2026030403075081100_bib43","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood.2024026212","article-title":"Impact of soluble BCMA and non\u2013T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma","volume":"144","author":"Lee","year":"2024","journal-title":"Blood"},{"key":"2026030403075081100_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41525-022-00340-x","article-title":"Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma","volume":"8","author":"Pilcher","year":"2023","journal-title":"NPJ Genom Med"},{"key":"2026030403075081100_bib45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-016-0345-3","article-title":"T cells in multiple myeloma display features of exhaustion and senescence at the tumor site","volume":"9","author":"Zelle-Rieser","year":"2016","journal-title":"J Hematol Oncol"},{"key":"2026030403075081100_bib46","doi-asserted-by":"crossref","first-page":"eadp6667","DOI":"10.1126\/sciimmunol.adp6667","article-title":"Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma","volume":"10","author":"Lutz","year":"2025","journal-title":"Sci Immunol"},{"key":"2026030403075081100_bib47","doi-asserted-by":"crossref","first-page":"844866","DOI":"10.3389\/fimmu.2022.844866","article-title":"Mechanisms of MHC-I downregulation and role in immunotherapy response","volume":"13","author":"Taylor","year":"2022","journal-title":"Front Immunol"},{"key":"2026030403075081100_bib48","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","article-title":"High-dimensional single-cell analysis of human natural killer cell heterogeneity","volume":"25","author":"Rebuffet","year":"2024","journal-title":"Nat Immunol"},{"key":"2026030403075081100_bib49","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s43018-024-00818-w","article-title":"Clinical response and pathway-specific correlates following TIGIT\u2013LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial","volume":"5","author":"Richard","year":"2024","journal-title":"Nat Cancer"},{"key":"2026030403075081100_bib50","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat Commun"},{"key":"2026030403075081100_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol"},{"key":"2026030403075081100_bib52","doi-asserted-by":"crossref","first-page":"giaa151","DOI":"10.1093\/gigascience\/giaa151","article-title":"SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data","volume":"9","author":"Young","year":"2020","journal-title":"GigaScience"},{"key":"2026030403075081100_bib53","doi-asserted-by":"crossref","first-page":"979","DOI":"10.12688\/f1000research.73600.2","article-title":"Doublet identification in single-cell sequencing data using scDblFinder","volume":"10","author":"Germain","year":"2022","journal-title":"F1000Res"},{"key":"2026030403075081100_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"2026030403075081100_bib55","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41592-018-0229-2","article-title":"Deep generative modeling for single-cell transcriptomics","volume":"15","author":"Lopez","year":"2018","journal-title":"Nat Methods"},{"key":"2026030403075081100_bib56","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1038\/s41598-019-41695-z","article-title":"From Louvain to Leiden: guaranteeing well-connected communities","volume":"9","author":"Traag","year":"2019","journal-title":"Sci Rep"},{"key":"2026030403075081100_bib57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"2026030403075081100_bib58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13059-019-1921-y","article-title":"Distinct epigenetic features of tumor-reactive CD8+ T cells in colorectal cancer patients revealed by genome-wide DNA methylation analysis","volume":"21","author":"Yang","year":"2019","journal-title":"Genome Biol"},{"key":"2026030403075081100_bib59","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-023-02371-y","article-title":"Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance","volume":"29","author":"Chu","year":"2023","journal-title":"Nat Med"},{"key":"2026030403075081100_bib60","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1038\/s41467-021-26951-z","article-title":"Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics","volume":"12","author":"Tirier","year":"2021","journal-title":"Nat Commun"},{"key":"2026030403075081100_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","article-title":"NicheNet: modeling intercellular communication by linking ligands to target genes","volume":"17","author":"Browaeys","year":"2020","journal-title":"Nat Methods"},{"key":"2026030403075081100_bib62","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41467-022-30755-0","article-title":"Comparison of methods and resources for cell-cell communication inference from single-cell RNA-Seq data","volume":"13","author":"Dimitrov","year":"2022","journal-title":"Nat Commun"},{"key":"2026030403075081100_bib63","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/leu.2017.29","article-title":"Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma","volume":"31","author":"Flores-Montero","year":"2017","journal-title":"Leukemia"},{"key":"2026030403075081100_bib64","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"key":"2026030403075081100_bib65","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-25-0170\/3670634\/bcd-25-0170.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-25-0170\/3732847\/bcd-25-0170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/7\/2\/250\/3740482\/bcd-25-0170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/7\/2\/250\/3740482\/bcd-25-0170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:08:05Z","timestamp":1772611685000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/7\/2\/250\/774790\/Composition-and-Functional-State-of-T-and-NK-Cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":65,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,14]]},"published-print":{"date-parts":[[2026,3,4]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-25-0170","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.31484068","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484056","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484002","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483960","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484014","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484020","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484074","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484032","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484062","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484080","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483948","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483966","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483954","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483978","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483996","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483972","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483984","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484023","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483993","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484059","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484047","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484053","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484041","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484011","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483969","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483987","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483999","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483951","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484017","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484005","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31483963","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.31484029","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.c.8335693","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]}}}